Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways

被引:11
|
作者
Therachiyil, Lubna [1 ,2 ]
Hussein, Ola J. [1 ]
Uddin, Shahab [2 ,3 ]
Korashy, Hesham M. [1 ,4 ]
机构
[1] Qatar Univ, Coll Pharm, Dept Pharmaceut Sci, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar
[3] Hamad Med Corp, Dermatol Inst, Acad Hlth Syst, Doha, Qatar
[4] Qatar Univ, Coll Pharm, Doha, Qatar
关键词
Aryl hydrocarbon receptor; Chemoresistance; Gynecological cancers; Stemness markers; Cancer stem cells; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN OVARIAN-CANCER; SIDE-POPULATION CELLS; BREAST-CANCER; ENDOMETRIAL CANCER; ALDEHYDE DEHYDROGENASE; AH-RECEPTOR; STEM/PROGENITOR CELLS; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR;
D O I
10.1016/j.semcancer.2022.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gynecological malignancies are a female type of cancers that affects the reproductive system. Cancer metastasis or recurrence mediated by cellular invasiveness occurs at advanced stages of cancer progression. Cancer Stem Cells (CSCs) enrichment in tumors leads to chemoresistance, which results in cancer mortality. Exposure to environmental pollutants such as polycyclic aromatic hydrocarbons is associated with an increased the risk of CSC enrichment in gynecological cancers. One of the important pathways that mediates the metabolism and bioactivation of these environmental chemicals is the transcription factor, aryl hydrocarbon receptor (AhR). The present review explores the molecular mechanisms regulating the crosstalk and interaction of the AhR with cancer-related signaling pathways, such as apoptosis, epithelial-mesenchymal transition, immune checkpoints, and G-protein-coupled receptors in several gynecological malignancies such as ovarian, uterine, endometrial, and cervical cancers. The review also discusses the potential of targeting the AhR pathway as a novel chemo-therapy for gynecological cancers.
引用
收藏
页码:1186 / 1202
页数:17
相关论文
共 50 条
  • [31] The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer
    Piwarski, Sean A.
    Salisbury, Travis B.
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
  • [32] Aryl hydrocarbon receptor (AhR) regulation of c-myc in human breast cancer cells.
    Yang, XH
    Kim, DW
    Murray, TJ
    Pachikara, BT
    Liu, DH
    Sonenshein, GE
    Sherr, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1211S - 1211S
  • [33] The Aryl Hydrocarbon Receptor Is Constitutively Active in Advanced Prostate Cancer Cells
    Richmond, Oliver
    Ghotbaddini, Maryam
    Allen, Cidney
    Walker, Alice
    Zahir, Shokouh
    Powell, Joann B.
    PLOS ONE, 2014, 9 (04):
  • [34] Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
    Kado, Sarah Y. Y.
    Bein, Keith
    Castaneda, Alejandro R. R.
    Pouraryan, Arshia A. A.
    Garrity, Nicole
    Ishihara, Yasuhiro
    Rossi, Andrea
    Haarmann-Stemmann, Thomas
    Sweeney, Colleen A. A.
    Vogel, Christoph F. A.
    CELLS, 2023, 12 (10)
  • [35] Activation of the aryl hydrocarbon receptor and down-regulation of the androgen receptor in prostate cancer cells by the curcumin analog 048
    Fajardo, Alexandra M.
    Bowles, Harmony J.
    MacKenzie, Debra A.
    Jagt, David L. Vander
    Bisoffi, Marco
    Thompson, Todd A.
    CANCER RESEARCH, 2010, 70
  • [36] Activation of the aryl hydrocarbon receptor and down-regulation of the androgen receptor in prostate cancer cells by the curcumin analog 048
    Fajardo, Alexandra M.
    Bowles, Harmony J.
    MacKenzie, Debra A.
    Jagt, David L. Vander
    Bisoffi, Marco
    Thompson, Todd A.
    CANCER RESEARCH, 2010, 70
  • [37] Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor
    Li, Shiyang
    Bostick, John W.
    Zhou, Liang
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [38] Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways
    Nie, MH
    Blankenship, AL
    Giesy, JP
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2001, 10 (1-2) : 17 - 27
  • [39] The aryl hydrocarbon receptor pathway and breast cancer
    Sakoff, Jennette
    Gilbert, Jayne
    Baker, Jennifer
    McCluskey, Adam
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 34 - 35
  • [40] The aryl hydrocarbon receptor as driver of cancer immunity
    Sherr, David
    Kenison-Whte, Jessica
    Wang, Zhongyan
    CANCER RESEARCH, 2018, 78 (13)